Profil
Alexander K.
Andrianov was the founder of Parallel Solutions, Inc. which was founded in 2001, where he held the title of Chief Scientific Officer in 2006.
Dr. Andrianov is also the founder of Neuimmune, Inc. Dr. Andrianov's former jobs include Director-Polymer Synthesis & Formulation at Celldex Therapeutics, Inc. and Vice President-Research & Development at Apogee Technology, Inc. Dr. Andrianov received a doctorate degree from Moscow State University Lomonosov in 1985.
Ehemalige bekannte Positionen von Alexander K. Andrianov
| Unternehmen | Position | Ende |
|---|---|---|
Parallel Solutions, Inc.
Parallel Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of polyphosphazene polymers | Gründer | 01.01.2006 |
Neuimmune, Inc.
Neuimmune, Inc. BiotechnologyHealth Technology Develops vaccines and biopharmaceuticals | Gründer | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Develops intradermal drug delivery systems for vaccines and other pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Alexander K. Andrianov
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Develops intradermal drug delivery systems for vaccines and other pharmaceuticals | Health Technology |
Parallel Solutions, Inc.
Parallel Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of polyphosphazene polymers | Commercial Services |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Neuimmune, Inc.
Neuimmune, Inc. BiotechnologyHealth Technology Develops vaccines and biopharmaceuticals | Health Technology |
















